Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

16 January 2014: Hypothesis  

Topical negative pressure improves autograft take by altering nutrient diffusion: A hypothesis

Xingang Wang ABCDEF , Yuanhai Zhang BCEF , Chunmao Han BDEFG

DOI: 10.12659/MSM.889861

Med Sci Monit 2014; 20:61-63

0 Comments

Abstract

ABSTRACT: The one-step surgical procedure for dermal substitutes combined with topical negative pressure (TNP) has proven effective for treating deep skin defects with improved graft take. The primary mechanism by which TNP improves autograft take is unknown. Some studies suggest that TNP promotes the rapid angiogenesis of dermal substitutes, improving graft take. However, at the early stage of one-step transplantation, the vascular system has not formed and imbibition is the main mode of nutrient supply. TNP can shorten the diffusion distance from the wound bed to the graft, leading to the timely renewal of the wound exudate via suction, removing any surplus exudate, and reducing tissue edema. In addition, TNP can regulate the local blood flow and inhibit bacterial colonization. Therefore, we hypothesized that TNP establishes a rapid balance between the nutrient supply to the wound bed and nutritional requirement of the graft via these pathways in the relatively closed, moist environment, improving autograft take. However, this balance could be affected by any negative pressure, intermittent or continuous. It is necessary to test this hypothesis in laboratory and clinical studies of the mode of nutrient supply in the imbibition phase and the change in exudate content.

Keywords: Autografts - growth & development, Models, Biological, Negative-Pressure Wound Therapy - methods, Regional Blood Flow - physiology, Skin - injuries, Wound Healing - physiology

Background

Dermal substitutes that serve as scaffolds for neotissue ingrowth and deposition have been introduced to the treatment of full-thickness skin defects [1]. For wounds, burns, and orthopedics, commercial substitutes such as Integra®, Pelnac®, MatriDerm®, and AlloDerm® have been used widely with one- or two-step surgical procedures [2–4].

The two-step surgical procedure is used most frequently. For example, Integra®, a bilayer dermal substitute developed by Yannas et al. [5,6], is a commercial collagen-based dermal substitute combined with a silicone top layer that functions as a temporary epidermis to keep the wound moist and to resist infection. The top layer is removed and replaced by a split-thickness autograft when the artificial dermis appears to be vascularized. This two-step procedure seems to be essential for vascularization of the scaffold to ensure that the split-thickness autograft takes. However, these dermal substitutes can take more than 3 weeks to become fully vascularized [7,8]. During this period, the risk of wound infection is high. With this approach, patients require at least 2 operations before complete wound closure.

Recently, the one-step procedure has become increasingly popular. One-step grafting involves the simultaneous application of the dermal substitute and a split-thickness skin graft to close the wound in a single operation. This approach enables earlier wound closure and avoids a second operation, but the presence of a non-vascularized dermal substitute acts as a barrier to nutrient diffusion to the autograft. Hence, graft loss is frequent. In the early stage, before complete vascularization of the dermal substitute, the graft survives only by the diffusion of nutrients from the wound bed. Any barrier between the graft and wound bed can inhibit this process and result in graft loss. The application of topical negative pressure (TNP) in the one-step procedure has been shown to improve graft take [9,10]. Some researchers stated that TNP reduces the time necessary for vascular ingrowth into the dermal substitute and improves graft take [9], although the exact mechanism and effect of TNP on graft take are not yet fully understood.

The Hypothesis

Topical negative pressure leads to a rapid balance between the nutrient supply from the wound bed and the nutritional requirements of the graft in the relatively closed, moist environment, and further improves the take of autografts.

Evaluation of the Hypothesis

Dermal substitutes, which lack a vascular structure, can be applied in a one-step surgical procedure to repair full-thickness skin defects. In the early stage of transplantation, the main nutrient supply is via simple diffusion from the wound bed and surrounding tissues (Figure 1). Then, angiogenesis begins and takes at least 3 weeks to finish [8]. Simple diffusion is an inefficient mode of nutrient supply and is affected by hematomas, seromas, infection, and dermal substitutes [11,12], as is the removal of metabolic products.

Topical negative pressure can shorten the diffusion distance from the wound bed to the graft and the suction ensures the timely renewal of the wound exudate. Since local tissue edema increases the after-load on capillaries and decreases the supply of oxygen, nutrients, and bioactive factors to the wound, TNP can remove the surplus wound exudate and reduce the tissue edema [13,14]. In addition, TNP can regulate the local blood flow and inhibit bacterial colonization. Therefore, TNP has the potential to improve the nutrient supply to wounds and promote wound healing (Figure 2).

The rapid angiogenesis of dermal substitutes is also very important for graft take. TNP promotes cell proliferation and penetration, and angiogenesis [15]. Molnar et al. used TNP to manage Integra®-treated complex tissue defects and observed an Integra® take rate of 96%, while split-thickness skin grafting performed at 4–11 days had a 93% take rate [16]. A prospective study by Moiemen et al. indicated that the application of TNP dressings to dermal templates reduced the shearing force, limited seroma and hematoma formation, simplified wound care, and improved patient comfort, but did not demonstrate that TNP accelerates neovascularisation as verified by the presence of histologically patent vascular channels [17]. Hence, the level of angiogenesis is not related to the improved autograft take in the one-step procedure. It appears that nutrient diffusion is critical for graft take before complete vascularization of the dermal substitute. In the early stage of transplantation, TNP affects the barrier resulting from the dermal substitute, and alters the mode of nutrient supply in the one-step surgical procedure. Moreover, TNP improves autograft take by establishing a rapid balance between the nutrient supply from the wound bed and nutritional requirements of the graft in the relatively closed, moist environment.

Conclusions and Future Perspectives

We hypothesized that TNP would result in a rapid balance between the nutrient supply from the wound bed and the nutritional requirements of the graft in the relatively closed, moist environment, improving the autograft take. However, this balance can be affected by the negative pressure and whether it is intermittent or continuous. One study showed that intermittent negative pressure has greater benefits in terms of cell ingress and local nutrient exchange [18]. Laboratory and clinical studies should test our hypothesis, especially the effects of TNP during the imbibition phase.

References

1. Groeber F, Holeiter M, Hampel M: Adv Drug Deliv Rev, 2011; 63(4–5); 352-66, pmid: 21241756

2. Ryssel H, Gazyakan E, Germann G, The use of MatriDerm in early excision and simultaneous autologous skin grafting in burns – a pilot study: Burns, 2008; 34(1); 93-97, pmid: 17644263

3. Wainwright D, Madden M, Luterman A, Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns: J Burn Care Rehabil, 1996; 17(2); 124-36, pmid: 8675502

4. Wainwright DJ, Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns: Burns, 1995; 21(4); 243-48, pmid: 7662122

5. Burke JF, Yannas IV, Quinby WC, Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury: Ann Surg, 1981; 194(4); 413-28, pmid: 6792993

6. Yannas IV, Burke JF, Warpehoski M, Prompt, long-term functional replacement of skin: Trans Am Soc Artif Intern Organs, 1981; 27; 19-23, pmid: 7036496

7. Stern R, McPherson M, Longaker MT, Histologic study of artificial skin used in the treatment of full-thickness thermal injury: J Burn Care Rehabil, 1990; 11(1); 7-13, pmid: 2179224

8. Moiemen NS, Staiano JJ, Ojeh NO, Reconstructive surgery with a dermal regeneration template: clinical and histologic study: Plast Reconstr Surg, 2001; 108(1); 93-103, pmid: 11420509

9. Bloemen MC, van der Wal MB, Verhaegen PD, Clinical effectiveness of dermal substitution in burns by topical negative pressure: a multicenter randomized controlled trial: Wound Repair Regen, 2012; 20(6); 797-805, pmid: 23110478

10. Jeschke MG, Rose C, Angele P, Development of new reconstructive techniques: use of Integra in combination with fibrin glue and negative-pressure therapy for reconstruction of acute and chronic wounds: Plast Reconstr Surg, 2004; 113(2); 525-30, pmid: 14758212

11. Greenhalgh DG, Clinical effectiveness of topical negative pressure for dermal substitutes in burns: Wound Repair Regen, 2012; 20(6); 791-92, pmid: 23110719

12. Wojcicki P, Drozdowski PH, In utero surgery – current state of the art – part II: Med Sci Monit, 2011; 17(12); RA262-70, pmid: 22129913

13. Morykwas MJ, Argenta LC, Shelton-Brown EI, Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation: Ann Plast Surg, 1997; 38(6); 553-62, pmid: 9188970

14. Plikaitis CM, Molnar JA, Subatmospheric pressure wound therapy and the vacuum-assisted closure device: basic science and current clinical successes: Expert Rev Med Devices, 2006; 3(2); 175-84, pmid: 16515384

15. Walgenbach KJ, Starck JB, Induction of angiogenesis following vacuum sealing: ZfW, 2000; 13; 9-10

16. Molnar JA, DeFranzo AJ, Hadaegh A, Acceleration of Integra incorporation in complex tissue defects with subatmospheric pressure: Plast Reconstr Surg, 2004; 113(5); 1339-46, pmid: 15060345

17. Moiemen NS, Yarrow J, Kamel D: Burns, 2010; 36(6); 764-68, pmid: 20494522

18. Mendonca DA, Papini R, Price PE, Negative-pressure wound therapy: a snapshot of the evidence: Int Wound J, 2006; 3(4); 261-71, pmid: 17199762

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750